News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,249 Results
Type
Article (41628)
Company Profile (272)
Press Release (682339)
Multimedia
Podcasts (80)
Webinars (18)
Section
Business (205455)
Career Advice (2039)
Deals (35589)
Drug Delivery (111)
Drug Development (81521)
Employer Resources (173)
FDA (16442)
Job Trends (15008)
News (347458)
Policy (32829)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2612)
Academic (1)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49875)
ALS (169)
Alzheimer's disease (1662)
Antibody-drug conjugate (ADC) (305)
Approvals (16707)
Artificial intelligence (506)
Autoimmune disease (147)
Automation (37)
Bankruptcy (363)
Best Places to Work (11666)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (178)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4759)
Cardiovascular disease (396)
Career advice (1721)
Career pathing (36)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (731)
Cervical cancer (36)
Clinical research (69585)
Collaboration (1675)
Company closure (4)
Compensation (1147)
Complete response letters (52)
COVID-19 (2722)
CRISPR (88)
C-suite (819)
Cystic fibrosis (143)
Data (6163)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (498)
Diagnostics (6699)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (243)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90130)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117585)
Executive appointments (961)
FDA (19528)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1457)
Gene editing (192)
Generative AI (42)
Gene therapy (587)
GLP-1 (963)
Government (4682)
Grass and pollen (6)
Guidances (383)
Healthcare (18901)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (104)
Infectious disease (2984)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (112)
Intellectual property (242)
Interviews (318)
IPO (16654)
IRA (49)
Job creations (3678)
Job search strategy (1440)
JPM (56)
Kidney cancer (15)
Labor market (84)
Layoffs (548)
Leadership (32)
Legal (7967)
Liver cancer (92)
Longevity (14)
Lung cancer (643)
Lymphoma (372)
Machine learning (42)
Management (59)
Manufacturing (779)
MASH (162)
Medical device (13789)
Medtech (13841)
Mergers & acquisitions (19994)
Metabolic disorders (1257)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (311)
Neuropsychiatric disorders (86)
Neuroscience (2881)
Neurotech (1)
NextGen: Class of 2026 (6539)
Non-profit (4538)
Now hiring (65)
Obesity (588)
Opinion (257)
Ovarian cancer (164)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (281)
Partnered (33)
Patents (488)
Patient recruitment (475)
Peanut (55)
People (59129)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21721)
Phase 2 (30620)
Phase 3 (22807)
Pipeline (5117)
Policy (280)
Postmarket research (2569)
Preclinical (9221)
Press Release (68)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (819)
Real estate (6016)
Recruiting (69)
Regulatory (24490)
Reports (51)
Research institute (2425)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (240)
Series B (186)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (41)
Startups (3636)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (85)
The Weekly (53)
Vaccines (990)
Venture capital (86)
Weight loss (378)
Women's health (87)
Worklife (18)
Date
Today (90)
Last 7 days (598)
Last 30 days (2030)
Last 365 days (29861)
2026 (2903)
2025 (30222)
2024 (35260)
2023 (40139)
2022 (51246)
2021 (55811)
2020 (54208)
2019 (46688)
2018 (35177)
2017 (32281)
2016 (31675)
2015 (37789)
2014 (31482)
2013 (26560)
2012 (28760)
2011 (29439)
2010 (27554)
Location
Africa (741)
Alabama (84)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39432)
Australia (6443)
California (11175)
Canada (3256)
China (1088)
Colorado (472)
Connecticut (470)
Delaware (333)
Europe (84954)
Florida (1663)
Georgia (354)
Hawaii (3)
Idaho (61)
Illinois (853)
India (62)
Indiana (515)
Iowa (22)
Japan (420)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1371)
Massachusetts (8016)
Michigan (319)
Minnesota (622)
Mississippi (6)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2974)
New Mexico (28)
New York (2947)
North Carolina (1437)
North Dakota (8)
Northern California (5444)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2258)
Puerto Rico (22)
Rhode Island (47)
South America (1116)
South Carolina (65)
South Dakota (1)
Southern California (4353)
Tennessee (174)
Texas (1727)
United States (39641)
Utah (333)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (915)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
724,249 Results for "paragon biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025
November 17, 2025
·
4 min read
Press Releases
Paragon Therapeutics Expands Executive Team to Advance Strategic Objectives
August 22, 2025
·
3 min read
Press Releases
Paragon Genomics and Genecast Announce Global Partnership to Advance Precision Oncology
July 31, 2025
·
4 min read
Press Releases
Zimmer Biomet Completes Acquisition of Paragon 28
April 21, 2025
·
6 min read
Press Releases
Lifecore Biomedical to be Added to Nasdaq Biotech Index
December 18, 2025
·
1 min read
Deals
Elevance Health Announces Closing of Paragon Healthcare Acquisition
Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
March 11, 2024
·
6 min read
Deals
Elevance Health to Acquire Paragon Healthcare
Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
January 4, 2024
·
7 min read
BioMidwest
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.
May 2, 2024
·
1 min read
Press Releases
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
February 9, 2026
·
6 min read
Business
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.
May 8, 2024
·
12 min read
1 of 72,425
Next
